Correlation of trastuzumab treatment benefit with quantitative HER2 expression levels in HER2 positive metastatic breast cancer.

被引：0

作者：

Bachmeier, Beatrice

Sperinde, Jeff

Weidler, Jodi Marie

Lie, Yolanda

Chenna, Ahmed

Winslow, John

Engel, Jutta

Schubert-Fritschle, Gabriele

Sommerhoff, Christian

Petropoulos, Christos J.

Bates, Michael Patrick

Huang, Weidong

Nerlich, Andreas

机构：

[1] Univ Munich, Inst Lab Med, Munich, Germany

[2] Monogram Biosci, San Francisco, CA USA

[3] Cepheid Inc, Sunnyvale, CA USA

[4] Univ Munich, Inst Med Informat Biostat & Epidemiol, Munich, Germany

[5] Univ Hosp Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany

[6] Home, Sunnyvale, CA USA

[7] Monogram Biosci Inc, LabCorp, Pleasanton, CA USA

[8] Munich Municipal Hosp, Munich, Germany

来源：

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.593

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

593

引用

页数：1